The Effect of Consuming on Body Composition and Blood Biochemistry Index
- Conditions
- Gut Microbiota
- Interventions
- Dietary Supplement: Fruit and vegetable solid drink
- Registration Number
- NCT04501601
- Lead Sponsor
- TCI Co., Ltd.
- Brief Summary
To assess the effect of consuming on body composition and blood biochemistry index
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 25
- Male or female aged between 20 and 60 years old
- Body mass index (BMI) ≥ 24 (kg/m^2) or body fat mass: male > 25%, female > 30%
- Prohibitions on other nutritional supplements (probiotics and prebiotics) before two weeks of the study
- Abidance by the similar diet and exercise habits over the study.
- Pregnant or breastfeeding woman
- Menopausal woman
- Diabetes mellitus
- Implementation in weight loss programs before a half year of this study
- Metabolic disorders
- Kidney diseases
- Liver diseases
- Cardiovascular diseases
- Nervous system diseases
- Gastrointestinal diseases
- Heavy drinking or constant drug use.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Experimental: weight loss program kit Fruit and vegetable solid drink weight loss program kit
- Primary Outcome Measures
Name Time Method The change of body fat mass Change from Baseline body fat mass at 2 months The body fat mass (kg) was assessed by InBody770.
The change of Triglyceride Change from Baseline triglyceride at 2 months Venous blood was sampled to measure concentrations of Triglyceride
The change of LDL-cholesterol Change from Baseline LDL-cholesterol at 2 months Venous blood was sampled to measure concentrations of LDL-cholestrol
The change of HDL-cholesterol Change from Baseline HDL-cholesterol at 2 months Venous blood was sampled to measure concentrations of HDL-cholestrol
Fecal microbiome analysis Change from Baseline Fecal microbiome at 2 months Firmicutes, Bacteroidetes, Lactobucillius, and A. muciniphila were quantified by quantitative PCR.
The change of body mass index (BMI) Change from Baseline body mass index at 2 months BMI is a measurement of a person's leanness or corpulence based on their height and weight, and is intended to quantify tissue mass.The body mass index (BMI, kg/m\^2) and body mass (kg) were assessed by InBody770.
The change of visceral fat Change from Baseline visceral fat at 2 months The visceral fat (10 cm\^2) was assessed by InBody770.
The change of Total cholesterol Change from Baseline total cholesterol at 2 months Venous blood was sampled to measure concentrations of Total cholestrol
The change of body fat percentage Change from Baseline body fat percentage at 2 months The body fat percentage (%) was assessed by InBody770
- Secondary Outcome Measures
Name Time Method The change of white blood cell Change from Baseline white blood cell at 2 months Venous blood was sampled to measure concentrations of white blood cell
The change of fasting glycemia Change from Baseline fasting glycemia at 2 months Venous blood was sampled to measure concentrations of fasting glycemia
The change of albumin Change from Baseline albumin at 2 months Venous blood was sampled to measure concentrations of albumin
The change of aspartate aminotransferase Change from Baseline aspartate aminotransferase at 2 months Venous blood was sampled to measure concentrations of aspartate aminotransferase
The change of uric acid Change from Baseline uric acid at 2 months Venous blood was sampled to measure concentrations of uric acid
The change of alanine aminotransferase Change from Baseline alanine aminotransferase at 2 months Venous blood was sampled to measure concentrations of alanine aminotransferase
The change of creatinine Change from Baseline creatinine at 2 months Venous blood was sampled to measure concentrations of creatine
Trial Locations
- Locations (1)
National Pingtung University of Science and Technology
🇨🇳Pingtung, Neipu Township, Taiwan